Dabifib 150 mg Capsule (10 Cap)

Medicine Information

About Dabifib 150 mg Capsule:

Each Dabifib 150 mg capsule contains Dabigatran Etexilate Mesylate Equivalent to Dabigatran Etexilate 150 mg, Excipients q.s.

Dabigatran etexilate belongs to a group of medicines called anticoagulants. It works by blocking a substance in the body which is involved in blood clot formation.

After administration, dabigatran etexilate (pro-drug) is rapidly converted to dabigatran (active drug) by esterase-catalyzed hydrolysis. Dabigatran is a potent, competitive, reversible direct thrombin inhibitor. It prevents the thrombin-mediated conversion of fibrinogen into fibrin during the coagulation cascade, which inhibits the development of thrombus.

Dabigatran also inhibits free thrombin, fibrin-bound thrombin, and thrombin-induced platelet aggregation.

Use of Dabifib 150 mg Capsule:

Dabifib 150 mg capsule is prescribed to:

• Reduce the risk of stroke & systemic embolism in patients with non-valvular atrial fibrillation (NVAF).
• Prevent postoperative venous thromboembolism (the formation of blood clots in the veins after knee or hip replacement surgery).
• Treat Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE).
• Reduce the risk of recurrence of Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE) in patients who have been previously treated.

Usage direction of Dabifib 150 mg Capsule:

Precautions And Related Information of Dabifib 150 mg Capsule :

•  If allergic to this medicine inform the physician immediately.
• If find any other complication inform the physician immediately.
• Precaution should be taken if you have a history of severely reduced kidney and liver functions.
• Individual with active bleeding or an increased tendency of bleeding should discuss with the healthcare professional prior to the treatment.
• Consult with the physician during pregnancy & lactation.
• Store below 30°C. Protect from moisture.
• Keep out of reach of children.